Studies of brain phenotypes in PMD human and Shank3 animal model studies show parallel findings of reduced brain volume and altered white matter phenotypes, potentially suggesting a cross-species structural biomarker. This evidence concerns the gene SHANK3 and Pelizeaus-Merzbacher spectrum disorder.